World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 18 April 2016
Main ID:  NCT02732197
Date of registration: 04/04/2016
Prospective Registration: No
Primary sponsor: Van Training and Research Hospital
Public title: Effects of Sedation on Spinal Anesthesia-induced Maternal Hypotension
Scientific title: Effects of Sedation on Spinal Anesthesia-induced Maternal Hypotension in Preoperatively Anxious Parturients Undergoing Urgent Category-1 Cesarean Section: A Historical Cohort Study
Date of first enrolment: August 2014
Target sample size: 102
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02732197
Study type:  Observational
Study design:  Observational Model: Cohort, Time Perspective: Retrospective  
Phase:  N/A
Countries of recruitment
Turkey
Contacts
Name:     Cenk Sahan, MD
Address: 
Telephone:
Email:
Affiliation:  Design and conduct the study, review and analyze the data, and write the manuscript
Key inclusion & exclusion criteria

Inclusion Criteria:

- Urgent category-1 C/S

- ASA physical status I-II

- Aged between 18 and 35 years

- Term (=37 weeks) singleton pregnancy

- BMI <40 kg/m2

- Height >150 cm or <180 cm

- High preoperative anxiety scores (visual analogue scale for anxiety (VAS-A) =70)

- Spinal anesthesia with thiopental sodium sedation

- Spinal anesthesia without any sedation

Exclusion Criteria:

- Preoperative prehydration

- Placenta previa

- Placenta accreta

- Hypertension

- Pregnancy-induced hypertension

- Urgent category =2

- General anesthesia

- Spinal anesthesia with sedation other than thiopental sodium



Age minimum: 18 Years
Age maximum: 35 Years
Gender: Female
Health Condition(s) or Problem(s) studied
Sedation
Maternal Hypotension
Preoperative Anxiety
Cesarean Section
Spinal Anesthesia
Intervention(s)
Drug: No sedation
Drug: Sedation
Primary Outcome(s)
Maximum systolic arterial pressure (SAP) reductions from the baseline values [Time Frame: 0-10 minutes]
Secondary Outcome(s)
Incidence of maternal nausea [Time Frame: 0-30 minutes]
Newborn Apgar score 5th min [Time Frame: 5th min]
Atropine requirement [Time Frame: 0-30 minutes]
Incidence of maternal hypotension [Time Frame: 0-30 minutes]
Newborn Apgar score 1st min [Time Frame: 1st min]
Ephedrine requirement [Time Frame: 0-30 minutes]
Incidence of maternal vomiting [Time Frame: 0-30 minutes]
Incidence of maternal bradycardia [Time Frame: 0-30 minutes]
Secondary ID(s)
2015/4
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history